Immunology and Microbiology
Caenorhabditis elegans
96%
Candida albicans
90%
Methicillin-Resistant Staphylococcus Aureus
54%
Staphylococcus aureus
52%
Biofilm
52%
Infectious Agent
51%
Galleria mellonella
47%
Candida
36%
Prevalence
33%
Cryptococcus neoformans
32%
Nematode
30%
COVID-19
24%
Virulence Factor
24%
Pathogenicity
22%
Minimum Inhibitory Concentration
21%
Antimicrobial Agent
19%
Filamentation
18%
Vancomycin-Resistant Enterococcus
16%
Antifungal Activity
15%
Probiotic
15%
Enterococcus faecalis
15%
Immune Response
15%
Medline
15%
Macrophage
15%
Penicillium marneffei
13%
Peptoclostridium difficile
13%
Innate Immune System
13%
Wild Type
13%
Enterococcus faecium
12%
Influenza
12%
Mortality Rate
12%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
12%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Immunity
12%
Quorum Sensing
11%
Hematopoietic Stem Cell Transplantation
11%
Human immunodeficiency virus
11%
Photodynamics
11%
Host Immune Response
11%
Virus Nucleocapsid
11%
Hypha
10%
Antimicrobial Activity
10%
Blood Plasma
10%
Colony-Forming Unit
9%
Colony Forming Unit S
9%
Acinetobacter Baumannii
9%
Magnetism
9%
Antimicrobial Peptides
9%
Lipid Bilayer
9%
Viral Load
8%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Antiinfective Agent
65%
Staphylococcus aureus
53%
Caenorhabditis elegans
46%
Diseases
40%
Methicillin-Resistant Staphylococcus Aureus
36%
Bloodstream Infection
34%
Candida
31%
Candida albicans
31%
Prevalence
27%
Antibiotics
27%
Antimicrobial Agent
25%
HIV
22%
Infectious Agent
21%
Antifungal Agent
20%
Clinical Trial
20%
Drug Discovery
19%
Placebo
18%
SARS Coronavirus
18%
Candidemia
17%
Randomized Controlled Trial
17%
Candidiasis
15%
Galleria mellonella
15%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
14%
Coronavirinae
14%
Cohort Study
14%
Meticillin
13%
Antimicrobial Resistance
12%
Mortality Rate
12%
Gentamicin
12%
Comorbidity
12%
Antifungal Therapy
12%
Antifungal Activity
11%
Mycosis
11%
Remdesivir
11%
Ebola Virus Disease
11%
Clostridium Difficile Infection
11%
Invasive Aspergillosis
10%
Vancomycin
10%
Nematode
9%
Virus Infection
9%
Photodynamic Therapy
9%
Biological Marker
9%
Antibacterial Activity
9%
Caffeic Acid Phenethyl Ester
8%
Urinary Tract Infection
8%
High-Throughput Screening
8%
Enterobacteriaceae
8%
Enterococcus faecium
8%
Amphotericin B
8%
Keyphrases
Meta-analysis
69%
Confidence Interval
58%
Systematic Meta-analysis
41%
COVID-19
20%
Vancomycin-resistant Enterococci
15%
Caenorhabditis Elegans
14%
Hospitalized Patients
14%
Bloodstream Infection
14%
Infection Risk
14%
Odds Ratio
13%
Methicillin-resistant Staphylococcus Aureus
11%
Risk Ratio
10%
Model Host
9%
Galleria Mellonella
9%
Solid Organ Transplant Recipients
9%
Enterococcus Faecalis
8%
Cumulative Incidence
8%
AIDS/HIV
8%
Staphylococcus Aureus Colonization
8%
Patients with COVID-19
8%
Dialysis Patients
8%
Extended-spectrum beta-lactamase-producing Enterobacteriaceae
8%
Clostridium Difficile Infection
8%
Embase
7%
Candida Albicans (C. albicans)
7%
C.albicans
7%
PubMed
7%
Staphylococcus Aureus
7%
Retrospective Cohort Study
7%
Hospitalization
7%
Pneumonia
7%
Risk Factors
7%
Invasive Aspergillosis
7%
Bacteremia
6%
Antifungal Drug Discovery
6%
Invertebrate Model
6%
Amphotericin B
6%
Antifungal Compounds
6%
Cryptococcal Meningitis
6%
Antifungal Agents
6%
Clinical Outcomes
6%
Candida
5%
Candida Colonization
5%
Steatotic Liver Disease
5%
Imdevimab
5%
Casirivimab
5%
Fusariosis
5%
Virological Marker
5%
Thymalfasin
5%
Enterobacteriaceae
5%